Early postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non-small cell lung cancer.

ABSTRACT:

SUBMITTER: Tang J 

PROVIDER: S-EPMC11469951 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature